AR020167A1 - Metodo para la prevencion del inicio del asma - Google Patents

Metodo para la prevencion del inicio del asma

Info

Publication number
AR020167A1
AR020167A1 ARP990104039A ARP990104039A AR020167A1 AR 020167 A1 AR020167 A1 AR 020167A1 AR P990104039 A ARP990104039 A AR P990104039A AR P990104039 A ARP990104039 A AR P990104039A AR 020167 A1 AR020167 A1 AR 020167A1
Authority
AR
Argentina
Prior art keywords
patient
cetiricin
asthma
onset
pharmaceutically acceptable
Prior art date
Application number
ARP990104039A
Other languages
English (en)
Spanish (es)
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26792214&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AR020167(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of AR020167A1 publication Critical patent/AR020167A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pulmonology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP990104039A 1998-08-18 1999-08-12 Metodo para la prevencion del inicio del asma AR020167A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US9692998P 1998-08-18 1998-08-18
US9745598P 1998-08-21 1998-08-21

Publications (1)

Publication Number Publication Date
AR020167A1 true AR020167A1 (es) 2002-04-10

Family

ID=26792214

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990104039A AR020167A1 (es) 1998-08-18 1999-08-12 Metodo para la prevencion del inicio del asma

Country Status (16)

Country Link
EP (1) EP1109557B1 (enExample)
JP (1) JP3878416B2 (enExample)
AR (1) AR020167A1 (enExample)
AT (1) ATE228366T1 (enExample)
AU (1) AU749169B2 (enExample)
CA (1) CA2340920C (enExample)
DE (1) DE69904206T2 (enExample)
ES (1) ES2188232T3 (enExample)
HN (1) HN1999000140A (enExample)
MA (1) MA26676A1 (enExample)
MY (1) MY124089A (enExample)
PA (1) PA8480401A1 (enExample)
SA (1) SA99200492B1 (enExample)
TN (1) TNSN99158A1 (enExample)
TW (1) TW581675B (enExample)
WO (1) WO2000010544A2 (enExample)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002221854A1 (en) * 2000-12-15 2002-06-24 U C B, S.A. Use of cetirizine or efletirizine for preventing urticaria
WO2005077371A1 (en) * 2004-02-12 2005-08-25 Ucb Farchim Sa Use of levocetirizine for the preparation of a drug
US8263581B2 (en) 2009-07-03 2012-09-11 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof
US8513259B2 (en) 2009-07-03 2013-08-20 Jdp Therapeutics, Inc. Non-sedating antihistamine injection formulations and methods of use thereof

Also Published As

Publication number Publication date
AU749169B2 (en) 2002-06-20
WO2000010544A2 (en) 2000-03-02
PA8480401A1 (es) 2000-09-29
DE69904206T2 (de) 2003-07-17
EP1109557A2 (en) 2001-06-27
ATE228366T1 (de) 2002-12-15
MY124089A (en) 2006-06-30
ES2188232T3 (es) 2003-06-16
HN1999000140A (es) 2001-07-31
EP1109557B1 (en) 2002-11-27
TW581675B (en) 2004-04-01
WO2000010544A3 (en) 2000-05-18
CA2340920A1 (en) 2000-03-02
AU5734699A (en) 2000-03-14
MA26676A1 (fr) 2004-12-20
CA2340920C (en) 2007-10-16
SA99200492B1 (ar) 2006-06-04
JP2002523362A (ja) 2002-07-30
DE69904206D1 (de) 2003-01-09
TNSN99158A1 (ar) 2005-11-10
JP3878416B2 (ja) 2007-02-07

Similar Documents

Publication Publication Date Title
JP5023315B2 (ja) 精神異常症の治療または予防処置のための、ミルタザピンと抗精神病剤の新規組み合わせ
CU23468B7 (es) Forma de dosificación de pramipexol en una dosis única diaria
AU2017236177B2 (en) Use of masitinib for treatment of an amyotrophic lateral sclerosis patient subpopulation
ES2263586T3 (es) Uso de pramipexol para el tratamiento de la adiccion al tabaco/nicotina.
TWI455723B (zh) 納曲酮及安非他酮於治療超重或肥胖病患之用途
TW200817049A (en) Epinephrine dosing regimens comprising buccal, lingual or sublingual and injectable dosage forms
ES2153338T1 (es) Dosificacion mejorada de dosis multiples de medicamentos.
AR045289A1 (es) Forma de dosificacion oral de liberacion controlada que comprende 4-(2-di-n-propilaminoetil) - 2(3h)-indolona (ropi-nirol) y uso de dicha forma de dosificacion para la elaboracion de un medicamento
JPS59193821A (ja) 抗不安薬としてのフルオキセチンの使用法
SK7532002A3 (en) Pharmaceutical formulations containing zolmitriptan
ES2236551T3 (es) Combinacion de principios activos para el tratamiento medico de toxicomanias.
KR970061244A (ko) 치매 치료용 약학 조성물
ATE254463T1 (de) Verwendung von valaciclovir zur herstellung eines arzneimittels zur behandlung von genitalherpes durch einmal tägliche verabreichung
RU2010109359A (ru) Азитромицин для лечения кожных заболеваний
JPH0637395B2 (ja) ジペプタイド誘導体を含有する、筋萎縮性側索硬化症を治療するための薬剤
AR035946A1 (es) Composiciones farmaceuticas estrogenicas para usar en el tratamiento de desordenes en mujeres perimenopausicas, menopausicas o posmenopausicas, y usos de dichas composiciones para la preparacion de medicamentos
WO2003079976A3 (en) A substance with sedative effect
AR020167A1 (es) Metodo para la prevencion del inicio del asma
BR0316131A (pt) Acetil-l-carnitina para a prevenção e/ou tratamento de neuropatias periféricas induzidas por agentes anti-câncer
ES2312657T3 (es) Utilizacion de desoxipeganina en el tratamiento de la depresion clinica.
CN104758445A (zh) 一种烟叶提取物及其在依赖治疗中的应用
ES2275619T3 (es) Quetiapina para el tratamiento de discinesia en pacientes no psicoticos.
JPH10506097A (ja) Ｊｅｔ ｌａｇを緩和するための方法と医薬
ES2303585T3 (es) Combinacion de glivec(sti571) con un inhibidor de quinasa dependiente de ciclina, especialmente flavopiridol en el tratamiento de cancer.
ES2398960T3 (es) Composición farmacéutica novedosa y su uso en un método para el tratamiento de pacientes con cangestión mucosa de las vías respiratorias altas

Legal Events

Date Code Title Description
FA Abandonment or withdrawal